History Salient Features Physical Exam

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

1 Oxypurinol for Gout Arthritis Drugs Advisory Committee June 2, 2004 Cardiome Pharma Corp Vancouver, BC Canada.
1. Describe the pathogenesis of hyperuricemia and gout Goup C1 Group C1.
Prepared by D. Chaplin Chronic Renal Failure. Prepared by D. Chaplin Chronic Renal Failure Progressive, irreversible damage to the nephrons and glomeruli.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
GOUT AND PSEUDOGOUT ANDRES QUICENO, MD Rheumatology Division
The Kidneys Major Topics for Discussion Review of anatomy and physiology Congenital anomalies Glomerular diseases Vascular diseases Kidney stones Neoplasia.
Glomerular Diseases Dr. Atapour Differential diagnosis and evaluation of glomerular disease.
Purine Degradation & Gout (Musculoskeletal Block)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Pathophysiology of Disease: Chapter 16 ( ) RENAL DISEASE: OVERVIEW AND ACUTE RENAL FAILURE Pathophysiology of Disease: Chapter 16 ( ) Jack.
Gout.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric acid xiaoli.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric Acid Metabolism & Gout
HYPERURICEMIA and GOUT PATHOGENESIS. HYPERURICEMIA Plasma/serum urate concentration >408 mol/L (6.8 mg/dL) Present in between 2.0 and 13.2% of ambulatory.
Renal Pathology. Introduction: 150gm: each kidney 1700 liters of blood filtered  180 L of G. filtrate  1.5 L of urine / day. Kidney is a retro-peritoneal.
Diagnosis of gout.
Kidneys and Urinary Tract
More than 100 different disorders
Ricki Otten MT(ASCP)SC
Primary glomerular diseases Talia Weinstein MD PhD Sourasky Medical Center.
Gout Gouty Arthritis By Mike Parenteau.
Obstructive Uropathy Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
SEVERE DISSEMINATED CUTANEOUS GOUT -CASE REPORT- Irina Tudose1, Olguta Anca Orzan2, Diana Petrache2, Prof. Dr. Calin Giurcaneanu2 1 Pathology Department,
History A 50 y/o was referred for evaluation of azotemia. 10 yrs ago, he experienced sudden onset of pain on his right big toe. His serum uric acid was.
Aims Renal Pathology Readings: Acute renal failure
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Pathology of pyelonephritis, Nephrolithiasis and Cystitis
Lecture – 3 – Major renal syndromes Dr.Hazem.K.Al-Khafaji MBCHB.D.M.FICMS.
Gout Treatment Megan Chan, PGY-2 UHCMC Gout Acute gouty arthritis = monosodium urate crystals in synovial fluid leukocytes – Serum urate ≥ 6.8 =
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
Renal Pathophysiology III : Diseases that affect the kidney and urinary tract Acute and chronic renal failure.
Clinical Decision on A Diagnostic Test. Clinical Question In a middle aged man with primary gout and azotemia, can a urine uric acid to creatinine ratio.
StagesClinical Features (1)Asymptomatic hyperuricemiahigh uric acid level is present but without symptoms (2) Acute Gouty Arthritishigh uric acid level.
Anna Pardue NS Methodist University.  As we known “Rich man’s disease.”  Inflammatory arthritis, a metabolic disorder that causes the deposition of.
GERIATRICS Dr. Meg-angela Christi Amores. Musculoskeletal Disorders in the Elderly  Osteoarthritis  Rheumatoid Arthritis  Gout (Gouty arthritis) 
Renal Disorders NUR 171 Professor Losicki R.N. MSN.
Be Aware Of Various Gout Treatments. Gout is a painful condition caused by a rise in the uric acid level in the blood. The uric acid that accumulates.
© Copyright Annals of Internal Medicine, 2016 Ann Int Med. 165 (1): ITC1-1. In the Clinic Gout.
Uric acid nephropathy 신장내과 R4 최선영. Endogenous production of uric acid Purine catabolism hypoxanthine xanthine Uric acid allantoin XO UO allopurinol -
Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
RENAL PATHOLOGY FOR REHABILITATION STUDENTS
Crystalopathies Joanna Zalewska.
TUBULOINTERSTITIAL DISEASES Al-Absi, M.D.
CLS 1113 Introduction to Clinical Laboratory Practices
Gout.
IgA nephropathy 2014년 8월 6일 R1 황규환.
Pathology for year 2, unit 3
presentation: nephrotic syndrome
Drug Therapy of Gout 1.
Disorders of Renal System
  URIC ACID Muthana A. Al-Shemeri.
Clinical Features. This disorder usually presents either with the
Mr. Smith, 51, came to the family doctor because of severe pain in his left knee. The patient gave the pain began suddenly at 2 am, woke him from his.
Gout By: Ben Shoaf.
Gouty Nephropathy American Journal of Kidney Diseases
IgA Nephropathy Southwest Nephrology Symposium February 24th 2018.
Purine Degradation & Gout (Musculoskeletal Block)
Purine Degradation & Gout (Musculoskeletal Block)
Slide 1: Target population/question
Presentation transcript:

History Salient Features Physical Exam A 50 y/o was referred for evaluation of azotemia. 10 yrs ago, he experienced sudden onset of pain on his right big toe. His serum uric acid was elevated. He was diagnosed to have gout and was prescribed medication but he was poorly compliant. The gouty attacks recurred lately hence, he decided to undergo thorough check-up. He denies dysuria, flank pain or hesitancy. He has nocturia. BP is 120/70 Obese numerous tophi in his metacarpo-phalangea l elbow joint no edema A 50 y/o obese male with longstanding hyperuricemia Patient experiences nocturia but there is no dysuria, flank pain or hesitancy, and edema BP is 120/70 Numerous tophi in his metacarpo-phalangeal elbow joint

Clinical Impression Gouty nephropathy Patients with prolonged forms of hyperuricemia are predisposed to a more chronic tubulointerstitial disorder Distinctive feature: presence of crystalline deposits of uric acid and monosodium urate salts in kidney parenchyma Clinically, gouty nephropathy is an insidious cause of renal insufficiency. Early in its course GFR may be near normal despite focal morphologic changes in medullary and cortical interstitium and diminished urinary concentrating ability - These deposits not only causes intrarenal obstruction but also incite an inflammatory response leading to lymphocytic infiltration, foreign-body giant cell reaction and eventual fibrosis Gout is a metabolic disease resulting from an increased body pool of urate due to an overproduction or underproduction of uric acid. It is characterized by episodic arthritis due to the deposition of monosodium urate crystals in joints and connective tissue tophi (just as seen in our patient), and the risk for deposition in the kidney interstitium or uric acid nephrolithiasis. Patients with prolonged forms of hyperuricemia (just as in the case of our patient who was diagnosed to have gout 10 years ago, was poorly compliant with his medications and now experiencing a recurrence of gouty attacks) are predisposed to a more chronic tubulointerstitial disorder, often referred to as gouty nephropathy, which is also known as chronic uric acid nephropathy. The distinctive feature of this type of disease is the presence of crystalline deposits of uric acid and monosodium urate salts in the kidney parenchyma. These deposits not only causes intrarenal obstruction but also incite an inflammatory response leading to lymphocytic infiltration, foreign-body giant cell reaction and eventual fibrosis. Clinically, gouty nephropathy is an insidious cause of renal insufficiency. Despite the focal morphologic changes in the medullary and cortical interstitium, proteinuria and diminished urinary concentrating ability, the glomerular filtration rate may be near normal.

Algorithm/Sequence of Events Renal Deposition of Urates Pelvic Calculi Parenchymal Urate (microtophi) Tubular Uric Acid (obstruction) Gout Renal Insufficiency

Differential Diagnosis Diabetic Nephropathy Kimmelstiel-Wilson syndrome a progressive kidney disease caused by angiopathy of capillaries in the kidney glomeruli characterized by nephrotic syndrome and diffuse glomerulosclerosis.

Spectrum of Disease Diagram Lower testing threshold Upper testing threshold Pretest probability Do nothing. Rule out the disease Treat the patient without waiting for more information Do additional diagnostic exams to confirm diagnosis (testing zone) 20 % 70% % 41%